Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Company Info
Contact US
Avirmax Biopharma
Technology
Overview
Contact US
Contributions
Contributors
Contributions
0 Contributors
1 / 0
1 / 0
1 Contributions
1 / 1
1 / 1
No authors found
Announcement
Avirmax Biopharma Completes First Cohort Enrollment in ABI-110 Gene Therapy Trial for Wet AMD, Including PCV.
Avirmax Biopharma
PR-01-25-NI-31
Feb 04, 2025
